Global and North America Limulus Amebocyte Lysate Market
Global and North America Limulus Amebocyte Lysate Market

Limulus Amebocyte Lysate Comprehensive Study by Type (Bacterial Endotoxins, Pyrogens - Biological Test), Application (Drug Testing, Clinical Diagnosis, Others) Players and Region - Global Market Outlook to 2023

Limulus Amebocyte Lysate Market Segmented into XX Submarkets. | Forecast Years: 2018- 2023  

Oct 2019 Edition 236 Pages 215 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Industry Background:
The Limulus amebocyte lysate test is a substitute method for the rabbit pyrogen test focussed on the detection of pyrogenic substances in germ-free parenteral medicines. The aim of Limulus amebocyte lysate is the evaluation and introduction to common day use of the LAL test gel-clot method for assay of bacterial endotoxins in the examined products. One of the most important aspects of the Limulus amebocyte lysate test is that it is in accordance with the latest demand of the European Pharmacopoeia Commission for the replacement of the animal-based tests in favor of alternative methods where possible and this projected the growth of the market in the forecast period.This growth is primarily driven by The Demand for the Quality of Drugs in Ever-Increasing is Surging and Advance in the Tests for the Purity of Human and Veterinary Drugs is Driving the Market.

Globally, a noticeable market trend is evident New Laboratory Method like Limulus Amebocyte Lysate (LAL) Test, Used for the Detection of Pyrogenic Endotoxins. Major Players, such as Lonza Group AG (Switzerland), Charles River Laboratories, Inc. (United States), ASSOCIATES OF CAPE COD, INC. (United States), Accumedi Solutions Co., Ltd. (China), Xiamen Bioendo Technology (China), Zhanjiang A&C Biological (China), Zhanjiang Bokang (china) and Fuzhou Xinbei (China) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Market Drivers
  • The Demand for the Quality of Drugs in Ever-Increasing is Surging
  • Advance in the Tests for the Purity of Human and Veterinary Drugs is Driving the Market

Market Trend
  • New Laboratory Method like Limulus Amebocyte Lysate (LAL) Test, Used for the Detection of Pyrogenic Endotoxins

Restraints
  • Strict Government Norms and Regulations

Opportunities
Technological Advancement and Development of the Limulus Amebocyte Lysate Test is Creates the opportunities for Market

AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization of the Report:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Bacterial Endotoxins
  • Pyrogens - Biological Test
By Application
  • Drug Testing
  • Clinical Diagnosis
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Demand for the Quality of Drugs in Ever-Increasing is Surging
      • 3.2.2. Advance in the Tests for the Purity of Human and Veterinary Drugs is Driving the Market
    • 3.3. Market Trends
      • 3.3.1. New Laboratory Method like Limulus Amebocyte Lysate (LAL) Test, Used for the Detection of Pyrogenic Endotoxins
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Limulus Amebocyte Lysate, by Type, Application and Region (value) (2012-2017)
    • 5.1. Introduction
  • 6. Limulus Amebocyte Lysate: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. Lonza Group AG (Switzerland)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. Charles River Laboratories, Inc. (United States)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. ASSOCIATES OF CAPE COD, INC. (United States)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. Accumedi Solutions Co., Ltd. (China)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. Xiamen Bioendo Technology (China)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. Zhanjiang A&C Biological (China)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. Zhanjiang Bokang (china)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. Fuzhou Xinbei (China)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
  • 7. Global Limulus Amebocyte Lysate Sale, by Type, Application and Region (value) (2018-2023)
    • 7.1. Introduction
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Company Basic Information, Sales Area and Its Competitors
  • Table 2. Company Basic Information, Sales Area and Its Competitors
  • Table 3. Company Basic Information, Sales Area and Its Competitors
  • Table 4. Company Basic Information, Sales Area and Its Competitors
  • Table 5. Company Basic Information, Sales Area and Its Competitors
  • Table 6. Company Basic Information, Sales Area and Its Competitors
  • Table 7. Company Basic Information, Sales Area and Its Competitors
  • Table 8. Company Basic Information, Sales Area and Its Competitors
  • Table 9. Research Programs/Design for This Report
  • Table 10. Key Data Information from Secondary Sources
  • Table 11. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Lonza Group AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 5. Lonza Group AG (Switzerland) Revenue: by Geography 2017
  • Figure 6. Charles River Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 7. Charles River Laboratories, Inc. (United States) Revenue: by Geography 2017
  • Figure 8. ASSOCIATES OF CAPE COD, INC. (United States) Revenue, Net Income and Gross profit
  • Figure 9. ASSOCIATES OF CAPE COD, INC. (United States) Revenue: by Geography 2017
  • Figure 10. Accumedi Solutions Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 11. Accumedi Solutions Co., Ltd. (China) Revenue: by Geography 2017
  • Figure 12. Xiamen Bioendo Technology (China) Revenue, Net Income and Gross profit
  • Figure 13. Xiamen Bioendo Technology (China) Revenue: by Geography 2017
  • Figure 14. Zhanjiang A&C Biological (China) Revenue, Net Income and Gross profit
  • Figure 15. Zhanjiang A&C Biological (China) Revenue: by Geography 2017
  • Figure 16. Zhanjiang Bokang (china) Revenue, Net Income and Gross profit
  • Figure 17. Zhanjiang Bokang (china) Revenue: by Geography 2017
  • Figure 18. Fuzhou Xinbei (China) Revenue, Net Income and Gross profit
  • Figure 19. Fuzhou Xinbei (China) Revenue: by Geography 2017
Some of the key companies/manufacturers profiled in the report
  • Lonza Group AG (Switzerland)
  • Charles River Laboratories, Inc. (United States)
  • ASSOCIATES OF CAPE COD, INC. (United States)
  • Accumedi Solutions Co., Ltd. (China)
  • Xiamen Bioendo Technology (China)
  • Zhanjiang A&C Biological (China)
  • Zhanjiang Bokang (china)
  • Fuzhou Xinbei (China)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation